Abnormalities in Host Defense Associated with HIV Infection

Clinics in Chest Medicine

Volumn 34, Issue 2, 2013, Pages 143-153

  Beck, James M ^a,b  

^a Eastern Colorado Veterans Health Care System   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

B lymphocytes; Bronchoalveolar lavage; HIV infections; Lung diseases; Macrophages, alveolar; T lymphocytes

Indexed keywords

CHEMOKINE RECEPTOR; TUMOR NECROSIS FACTOR;

ANTIBODY RESPONSE; ANTIGEN PRESENTATION; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMOTAXIS; CYTOKINE RESPONSE; CYTOLYSIS; DISEASE ASSOCIATION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC ALVEOLITIS; MICROORGANISM; NEUTROPHIL; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; VIRAL TROPISM;

HIV INFECTIONS; HUMANS; LUNG; LUNG DISEASES; LYMPHOCYTES; MACROPHAGES, ALVEOLAR; NEUTROPHILS;

EID: 84878163490     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2013.01.003     Document Type: Review

References (107)

1. Beck J.M. The immunocompromised host: HIV infection. Proc Am Thorac Soc 2005, 2:423-427.
2. Agostini C., Zambello R., Trentin L., et al. HIV and pulmonary immune responses. Immunol Today 1996, 17:359-364.
3. Beck J.M., Rosen M.J., Peavy H.H. Pulmonary complications of HIV infection: report of the fourth NHLBI workshop. Am J Respir Crit Care Med 2001, 164:2120-2126.
4. White N.C., Agostini C., Israël-Biet D., et al. The growth and the control of human immunodeficiency virus in the lung: implications for highly active antiretroviral therapy. Eur J Clin Invest 1999, 29:964-972.
5. Centers for Disease Control and Prevention Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. MMWR 2009, 58:1-207.
6. Atzori C., Clerici M., Trabattoni D., et al. Assessment of immune reconstitution to Pneumocystis carinii in HIV-1 patients under different highly active antiretroviral therapy regimens. J Antimicrob Chemother 2003, 52:276-281.
7. Djawe K., Huang L., Daly K.R., et al. Serum antibody levels to the Pneumocystis jirovecii major surface glycoprotein in the diagnosis of P. jirovecii pneumonia in HIV+ patients. PLoS One 2010, 5:e14259.
8. Gingo M.R., Lucht L., Daly K.R., et al. Serologic responses to Pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia. J Acquir Immune Defic Syndr 2011, 57:190-196.
9. Benfield T.L., Lundgren J.D., Masur H. HIV-1, cytokines, and the lung. Cytokines in pulmonary disease: infection and inflammation 2000, 331-364. Marcel Dekker, New York. S. Nelson, T.R. Martin (Eds.).
10. Guay L.A., Sierra-Madero J.G., Finegan C.K., et al. Mediation of entry of human immunodeficiency virus-1 into alveolar macrophages by CD4 without facilitation by surfactant-associated protein-A. Am J Respir Cell Mol Biol 1997, 16:421-428.
11. Park I.W., Koziel H., Hatch W., et al. CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor. Am J Respir Cell Mol Biol 1999, 20:864-871.
12. An P., Li R., Wang J.M., et al. Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with Pneumocystis pneumonia. PLoS Genet 2011, 7:e1002328.
13. Salahuddin S.Z., Rose R.M., Groopman J.E., et al. Human T lymphotropic virus type III infection of human alveolar macrophages. Blood 1986, 68:281-284.
14. Abbud R.A., Finegan C.K., Guay L.A., et al. Enhanced production of human immunodeficiency virus type 1 by in vitro-infected alveolar macrophages from otherwise healthy cigarette smokers. J Infect Dis 1995, 172:859-863.
15. De Maria A., Pantaleo G., Schnittman S.M., et al. Infection of CD8+ lymphocytes: requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells. J Immunol 1991, 146:2220-2226.
16. Semenzato G., Agostini C., Ometto L., et al. CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. Blood 1995, 85:2308-2314.
17. Agostini C., Trentin L., Zambello R., et al. HIV-1 and the lung: infectivity, pathogenic mechanisms and cellular immune responses taking place in the lower respiratory tract. Am Rev Respir Dis 1993, 147:1038-1049.
18. Rose R.M., Krivine A., Pinkston P., et al. Frequent identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with the acquired immunodeficiency syndrome. Am Rev Respir Dis 1991, 143:850-854.
19. Sierra-Madero J.G., Toossi Z., Hom D.L., et al. Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status. J Infect Dis 1994, 169:18-27.
20. Lewin S.R., Kirihara J., Sonza S., et al. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals. AIDS 1998, 12:719-727.
21. Brenchley J.M., Knox K.S., Asher A.I., et al. High frequencies of polyfunctional HIV-specific T cells are associated with preservation of mucosal CD4 T cells in bronchoalveolar lavage. Mucosal Immunol 2008, 1:49-58.
22. Orenstein J.M., Fox C., Wahl S.M. Macrophages as a source of HIV during opportunistic infections. Science 1997, 276:1857-1861.
23. Nakata K., Rom W.N., Honda Y., et al. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med 1997, 155:996-1003.
24. Fraziano M., Cappelli G., Santucci M., et al. Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection. AIDS Res Hum Retroviruses 1999, 15:869-874.
25. Wahl S.M., Greenwell-Wild T., Hale-Donze H., et al. Permissive factors for HIV-1 infection of macrophages. J Leukoc Biol 2000, 68:303-310.
26. Koziel H., Kim S., Reardon C., et al. Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1999, 160:2048-2055.
27. Israël-Biet D., Esvant H., Laval A.M., et al. Impairment of beta chemokine and cytokine production in patients with HIV related Pneumocystis jiroveci pneumonia. Thorax 2004, 59:247-251.
28. White D.A., Gellene R.A., Gupta S., et al. Pulmonary cell populations in the immunosuppressed patient: bronchoalveolar lavage findings during episodes of pneumonitis. Chest 1985, 88:352-359.
29. Young K.R., Rankin J.A., Naegel G.P., et al. Bronchoalveolar lavage cells and proteins in patients with the acquired immunodeficiency syndrome: an immunologic analysis. Ann Intern Med 1985, 103:522-533.
30. Wewers M.D., Diaz P.T., Wewers M.E., et al. Cigarette smoking in HIV infection induces a suppressive inflammatory environment in the lung. Am J Respir Crit Care Med 1998, 158:1543-1549.
31. Hermier F., Comby E., Delaunay A., et al. Decreased blood TcRγδ+ lymphocytes in AIDS and p24-antigenemic HIV-1-infected patients. Clin Immunol Immunopathol 1993, 69:248-250.
32. Kägi M.K., Fierz W., Grob P.J., et al. High proportion of gamma-delta T cell receptor positive T cells in bronchoalveolar lavage and peripheral blood of HIV-infected patients with Pneumocystis carinii pneumonias. Respiration 1993, 60:170-177.
33. Rubbo P.A., Tuaillon E., Balloré K., et al. The potential impact of CD4+ T cell activation and enhanced Th1/Th2 cytokine ratio on HIV-1 secretion in the lungs of individuals with advanced AIDS and active pulmonary infection. Clin Immunol 2011, 139:142-154.
34. Agostini C., Adami F., Poulter L.W., et al. Role of bronchoalveolar lavage in predicting survival of patients with human immunodeficiency virus infection. Am J Respir Crit Care Med 1997, 156:1501-1507.
35. Day R.B., Wang Y., Knox K.S., et al. Alveolar macrophages from HIV-infected subjects are resistant to Mycobacterium tuberculosis in vitro. Am J Respir Cell Mol Biol 2004, 30:403-410.
36. McCune J.M. The dynamics of CD4+ T-cell depletion in HIV disease. Nature 2001, 410:974-979.
37. Rudy T., Opelz G., Gerlack R., et al. Correlation of in vitro immune defects with impaired gamma interferon response in human-immunodeficiency-virus-infected individuals. Vox Sang 1988, 54:92-95.
38. Krowka J., Stites D., Mills J., et al. Effects of interleukin 2 and large envelope glycoprotein (gp120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus. Clin Exp Immunol 1988, 72:179-185.
39. Alcocer-Varela J., Alarcon-Segovia D., Abud-Mendoza C. Immunoregulatory circuits in the acquired immune deficiency syndrome and related complex. Production of and response to interleukins 1 and 2, NK function and its enhancement by interleukin-2 and kinetics of the autologous mixed lymphocyte reaction. Clin Exp Immunol 1985, 60:31-38.
40. Sheridan J.F., Aurelian L., Donnenberg A.D., et al. Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses. J Clin Immunol 1984, 4:304-311.
41. Sereti I., Lane H.C. Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies. Clin Infect Dis 2001, 32:1738-1755.
42. INSIGHT-ESPRIT Study Group Predictors of bacterial pneumonia in evaluation of subcutaneous interleukin-2 in a randomized international trial (ESPRIT). HIV Med 2010, 12:219-227.
43. Murray H.W., Gellene R.A., Libby D.M., et al. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-γ. J Immunol 1985, 135:2374-2377.
44. Murray H.W., Scavuzzo D.A., Kelly C.D., et al. T4+ cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome. Arch Intern Med 1988, 148:1613-1616.
45. Murray H.W., Hillman J.K., Rubin B.Y., et al. Patients at risk for AIDS-related opportunistic infections: clinical manifestations and impaired gamma interferon production. N Engl J Med 1985, 313:1504-1510.
46. Aabye M.G., Ravn P., PrayGod G., et al. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One 2009, 4:e4220.
47. Clerici M., Shearer G.M. A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993, 14:107-111.
48. Clerici M., Lucey D.R., Berzofsky J.A., et al. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 1993, 262:1721-1724.
49. Jambo K.C., Sepako E., Fullerton D.G., et al. Bronchoalveolar CD4+ T cell responses to respiratory antigens are impaired in HIV-infected adults. Thorax 2011, 66:375-382.
50. Autran B., Sadat-Sowti B., Hadida F., et al. HIV-specific cytotoxic T lymphocytes against alveolar macrophages: specificities and downregulation. Res Virol 1991, 142:113-118.
51. Autran B., Plata F., Guillon J.M., et al. HIV-specific cytotoxic T lymphocytes directed against alveolar macrophages in HIV-infected patients. Res Virol 1990, 141:131-136.
52. Twigg H.L., Soliman D.M., Day R.B., et al. Lymphocytic alveolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection. Am J Respir Crit Care Med 1999, 159:1439-1444.
53. Agostini C., Zambello R., Facco M., et al. CD8 T-cell infiltration in extravascular tissues of patients with human immunodeficiency virus infection: interleukin-15 upmodulates costimulatory pathways involved in the antigen-presenting cells-T-cell interaction. Blood 1999, 93:1277-1286.
54. Semenzato G. Immunology of interstitial lung diseases: cellular events taking place in the lung of sarcoidosis, hypersensitivity pneumonitis and HIV infection. Eur Respir J 1991, 4:94-102.
55. Shearer G.M., Bernstein D.C., Tung K.S., et al. A model for the selective loss of major histocompatibility complex self-restricted T cell immune response during the development of acquired immune deficiency syndrome (AIDS). J Immunol 1986, 137:2514-2521.
56. Fiala M., Herman V., Gornbein J. Role of CD8+ in late opportunistic infections of patients with AIDS. Res Immunol 1992, 143:903-907.
57. Barry S.M., Johnson M.A., Janossy G. Increased proportions of activated and proliferating memory CD8+ T lymphocytes in both blood and lung are associated with blood HIV viral load. J Acquir Immune Defic Syndr 2003, 34:351-357.
58. Levacher M., Hulstaert F., Tallet S., et al. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin Exp Immunol 1992, 90:376-382.
59. Lieberman J., Shankar P., Manjanath N., et al. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 2001, 98:1667-1677.
60. Twigg H.L., Spain B.A., Soliman D.M., et al. Production of interferon-gamma by lung lymphocytes in HIV-infected individuals. Am J Physiol 1999, 276:L256-L262.
61. McMichael A.J., Rowland-Jones S.L. Cellular immune responses to HIV. Nature 2001, 410:980-987.
62. Herberman R.B. Adoptive therapy with purified CD8 cells in HIV infection. Semin Hematol 1992, 29:35-40.
63. Ho M., Armstrong J., McMahon D., et al. A phase 1 study of adoptive transfer of autologous CD8+ T lymphocytes in patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS. Blood 1993, 81:2093-2101.
64. Agostini C., Poletti V., Zambello R., et al. Phenotypical and functional analysis of bronchoalveolar lavage lymphocytes in patients with HIV infection. Am Rev Respir Dis 1988, 138:1609-1615.
65. Agostini C., Zambello R., Trentin L., et al. Cytotoxic events taking place in the lung of patients with HIV-1 infection: evidence of an intrinsic defect of the major histocompatibility complex-unrestricted killing partially restored by the incubation with rIL-2. Am Rev Respir Dis 1990, 142:516-522.
66. Poli G., Introna M., Zanaboni F., et al. Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin Exp Immunol 1985, 62:128-135.
67. Rao P.V., Ramanavelan S., Rajasekaran S., et al. Natural-killer cell-derived cytolytic molecules in HIV-associated pulmonary tuberculosis - role of exogenous interleukins. J Clin Immunol 2010, 30:393-401.
68. Rankin J.A., Walzer P.D., Dwyer J.M., et al. Immunologic alterations in bronchoalveolar lavage fluid in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis 1983, 128:189-194.
69. Twigg H.L., Spain B.A., Soliman D.M., et al. Impaired IgG production in the lungs of HIV-infected individuals. Cell Immunol 1996, 170:127-133.
70. Breen E.C., Rezai A.R., Nakajima K., et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990, 144:480-484.
71. Lane H.C., Masur H., Edgar L.C., et al. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983, 309:453-458.
72. Eagan R., Twigg H.L., French N., et al. Lung fluid immunoglobulin from HIV-infected subjects has impaired opsonic function against pneumococci. Clin Infect Dis 2007, 44:1632-1638.
73. Poli G., Bottazzi B., Acero R., et al. Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis. Clin Exp Immunol 1985, 62:136-142.
74. Nielsen H., Kharazmi A., Faber V. Blood monocyte and neutrophil functions in the acquired immune deficiency syndrome. Scand J Immunol 1986, 24:291-296.
75. Musher D.M., Watson D.A., Nickeson D., et al. The effect of HIV infection on phagocytosis and killing of Staphylococcus aureus by human pulmonary alveolar macrophages. Am J Med 1990, 299:158-163.
76. Ezekowitz R.A., Williams D.J., Koziel H., et al. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 1991, 351:155-158.
77. Koziel H., Eichbaum Q., Kruskal B.A., et al. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J Clin Invest 1998, 102:1332-1344.
78. Elssner A., Carter J.E., Yunger T.M., et al. HIV-1 infection does not impair human alveolar macrophage phagocytic function unless combined with cigarette smoking. Chest 2004, 125:1071-1076.
79. Murray H.W., Rubin B.Y., Masur H., et al. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med 1984, 310:883-889.
80. Rich E.A., Toossi Z., Fujiwara H., et al. Defective accessory function of monocytes in human immunodeficiency virus-related disease syndromes. J Lab Clin Med 1988, 112:174-181.
81. Twigg H.L., Lipscomb M.F., Yoffe B., et al. Enhanced accessory cell function by alveolar macrophages from patients infected with the human immunodeficiency virus: potential role for depletion of CD4+ cells in the lung. Am J Respir Cell Mol Biol 1989, 1:391-400.
82. Macatonia S.E., Lau R., Patterson S., et al. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 1990, 71:38-45.
83. Macatonia S.E., Taylor P.M., Knight S.C., et al. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med 1989, 169:1255-1264.
84. Lähdevirta J., Maury C.P., Teppo A.M., et al. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988, 85:289-291.
85. Wright S.C., Jewett A., Mitsuyasu R., et al. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J Immunol 1988, 141:99-104.
86. Ammann A.J., Palladino M.A., Volberding P., et al. Tumor necrosis factor alpha and beta in acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Clin Immunol 1987, 7:481-485.
87. Molina J.M., Scaden D.T., Amirault C., et al. Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells. J Virol 1990, 64:2901-2906.
88. Israël-Biet D., Cadranel J., Beldjord K., et al. Tumor necrosis factor production in HIV-seropositive subjects: relationship with lung opportunistic infections and HIV expression in alveolar macrophages. J Immunol 1991, 147:490-494.
89. Gordon M.A., Gordon S., Musaya L., et al. Primary macrophages from HIV-infected adults show dysregulated cytokine responses to Salmonella, but normal internalization and killing. AIDS 2007, 21:2399-2408.
90. Tachado S.D., Zhang J., Zhu J., et al. HIV impairs TNF-alpha release in response to toll-like receptor 4 stimulation in human macrophages in vitro. Am J Respir Cell Mol Biol 2005, 33:610-621.
91. Han H., Li X., Yue S.C., et al. Epigenetic regulation of tumor necrosis factor α (TNFα) release in human macrophages by HIV-1 single-stranded RNA (ssRNA) is dependent on TLR8 signaling. J Biol Chem 2012, 287:13778-13786.
92. Tamburrini E., De Luca A., Ventura G., et al. Pneumocystis carinii stimulates in vitro production of tumor necrosis factor-alpha by human macrophages. Med Microbiol Immunol 1991, 180:15-20.
93. Krishnan V.L., Meager A., Mitchell D.M., et al. Alveolar macrophages in AIDS patients: Increased spontaneous tumour necrosis factor-alpha production in Pneumocystis carinii pneumonia. Clin Exp Immunol 1990, 80:156-160.
94. Rayment N., Miller R.F., Ali N., et al. Synthesis of tumor necrosis factor-alpha mRNA in bronchoalveolar lavage cells from human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia. J Infect Dis 1996, 174:654-659.
95. Huang Z.B., Eden E. Effect of corticosteroids on IL1 beta and TNF alpha release by alveolar macrophages from patients with AIDS and Pneumocystis carinii pneumonia. Chest 1993, 104:751-755.
96. Wallace J.M., Barbers R.G., Oishi J.S., et al. Cellular and T-lymphocyte subpopulation profiles in bronchoalveolar lavage fluid from patients with acquired immunodeficiency syndrome and pneumonitis. Am Rev Respir Dis 1984, 130:786-790.
97. Meddows-Taylor S., Pendle S., Tiemessen C.T. Altered expression of CD88 and associated impairment of complement 5a-induced neutrophil responses in human immunodeficiency virus type 1-infected patients with and without pulmonary tuberculosis. J Infect Dis 2001, 183:662-665.
98. Bandres J.C., Trial J., Musher D.M., et al. Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage 1 human immunodeficiency virus infections. J Infect Dis 1993, 168:75-83.
99. Baldwin G.C., Gasson J.C., Quan S.G., et al. Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. Proc Natl Acad Sci U S A 1988, 85:2763-2766.
100. Roilides E., Walsh T.J., Pizzo P.A., et al. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 1991, 163:579-583.
101. Armbruster C., Krugluger W., Huber M., et al. Immunoglobulin G Fc(gamma) receptor expression on polymorphonuclear cells in bronchoalveolar lavage fluid of HIV-infected and HIV-seronegative patients with bacterial pneumonia. Clin Chem Lab Med 2004, 42:192-197.
102. Limper A.H., Offord K.P., Smith T.F., et al. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989, 140:1204-1209.
103. Mason G.R., Hashimoto C.H., Dickman P.S., et al. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am Rev Respir Dis 1989, 139:1336-1342.
104. Azoulay E., Parrot A., Flahault A., et al. AIDS-related Pneumocystis carinii pneumonia in the era of adjunctive steroids: implication of BAL neutrophilia. Am J Respir Crit Care Med 1999, 160:493-499.
105. Laursen A.L., Obel N., Rungby J., et al. Phagocytosis and stimulation of the respiratory burst in neutrophils by Pneumocystis carinii. J Infect Dis 1993, 168:1466-1471.
106. Laursen A.L., Obel N.S., Holmskov U., et al. Activation of the respiratory burst by Pneumocystis carinii. Efficiency of different antibody isotypes, complement, lung surfactant protein D, and mannan-binding lectin. APMIS 2003, 111:405-415.
107. Benfield T.L., Vestbo J., Junge J., et al. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1995, 151:1058-1062.